Market Cap : 53.81 M | Enterprise Value : 49.09 M | PE Ratio : At Loss | PB Ratio : 17.00 |
---|
NAS:REFR has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:REFR has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.
Research Frontiers's Capital Expenditure for the three months ended in Mar. 2022 was $-0.00 Mil. Its Revenue for the three months ended in Mar. 2022 was $0.17 Mil.
Hence, Research Frontiers's Capex-to-Revenue for the three months ended in Mar. 2022 was 0.01.
The historical data trend for Research Frontiers's Capex-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Electronic Components subindustry, Research Frontiers's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Hardware industry and Technology sector, Research Frontiers's Capex-to-Revenue distribution charts can be found below:
* The bar in red indicates where Research Frontiers's Capex-to-Revenue falls into.
Research Frontiers's Capex-to-Revenue for the fiscal year that ended in Dec. 2021 is calculated as
Capex-to-Revenue | = | - Capital Expenditure | / | Revenue |
= | - (-0.001) | / | 1.263 | |
= | 0.00 |
Research Frontiers's Capex-to-Revenue for the quarter that ended in Mar. 2022 is calculated as
Capex-to-Revenue | = | - Capital Expenditure | / | Revenue |
= | - (-0.001) | / | 0.174 | |
= | 0.01 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.
Thank you for viewing the detailed overview of Research Frontiers's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Douglas Family Trust | 10 percent owner, other: 13(d)(3) group | 125 E. SIR FRANCIS DRAKE BLVD. SUITE 400 LARKSPUR CA 94939 |
James & Jean Douglas Irrevocable Descendants Trust | 10 percent owner, other: 13(d)(3) group | 125 E. SIR FRANCIS DRAKE BLVD. SUITE 400 LARKSPUR CA 94939 |
Douglas Kevin | 10 percent owner, other: 13(d)(3) group | 125 E. SIR FRANCIS DRAKE BLVD. SUITE 400 LARKSPUR CA 94939 |
Settle William Graham | director | 6003 COBRIDGE SQUARE RALEIGH NC 27609 |
Lapointe Michael R | officer: VP-Marketing | PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"> Ownership Information: LAPOINTE MICHAEL R a.header:link {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:visited {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:hover {color: #191970;} |
Harary Joseph M | director, officer: President and CEO | PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"> Ownership Information: HARARY JOSEPH M a.header:link {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:visited {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:hover {color: #191970;} |
Van Voorhees Seth | officer: CFO & VP-Business Development | 12 HARVEY DRIVE SHORT HILLS NJ 07078 |
Daigle Darryl | director | 3213 WYTCHWOOD DRIVE MORGAN CITY LA 70380 |
Kaganowicz Alexander | director | 1217 CARLLS STRAIGHT PATH DIX HILLS NY 11746 |
Grimes Gregory George | director | 24 FIFTH AVENUE APT. 1530 NEW YORK NY 10011 |
Slovak Steven Michael | officer: Vice President-Technology | 240 CROSSWAYS PARK DRIVE WOODBURY NY 11797 |
Saxe Robert L | director, officer: Chairman of the Board | PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"> Ownership Information: SAXE ROBERT L a.header:link {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:visited {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:hover {color: #191970;} |
Keen Victor F | director | C/O RESEARCH FRONTIERS INC. 240 CROSSWAYS PARK DRIVE WOODBURY NY 11797 |
Guthrie Marion Philip | director | THREE LINCOLN CENTRE 5430 LBJ FWY., SUITE 1480 DALLAS TX 75240 |
Derby Jack | director | 399 BOYLSTON STREET BOSTON MA 02117 |
From GuruFocus
Other Sources
By Seekingalpha 2021-11-09